Altimmune, Inc.
(NASDAQ : ALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
CPRTCopart, Inc.
-6.33%52.584.5%$126.59m
ETSYEtsy, Inc.
-2.48%47.547.9%$117.98m
EFXEquifax Inc.
-0.08%133.422.0%$97.37m
BZUNBaozun Inc Sponsored ADR Class A
0.77%48.591.7%$96.17m
FLTFleetCor Technologies, Inc.
0.06%222.323.4%$95.43m
ULTIUltimate Software Group, Inc.
-0.55%312.619.9%$82.07m
CTASCintas Corporation
0.01%211.704.5%$77.44m
ITGartner, Inc.
0.99%158.462.4%$75.73m
ZZillow Group, Inc. Class C
-4.16%42.8110.3%$74.69m
TRUTransUnion
-1.58%74.330.9%$73.31m
XRXXerox Corporation
-1.72%28.005.3%$70.42m
RLGYRealogy Holdings Corp.
-0.07%20.593.4%$64.89m
CDKCDK Global Inc
0.51%63.172.2%$57.86m
PRAHPRA Health Sciences, Inc.
-0.64%107.782.4%$48.20m
BAHBooz Allen Hamilton Holding Corporation Class A
-0.30%49.581.9%$42.74m

Company Profile

Altimmune, Inc. is a clinical stage company, which engages in the research and development of immunotherapeutic products. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.